IMPACT Publications

Bancroft, E.K., Page, E.C., Castro, E., Lilja, H., Vickers, A., Sjoberg, D., Assel, M., Foster, C.S., Mitchell, G., Drew, K., Mæhle, L., Axcrona, K., Evans, D.G., Bulman, B., Eccles, D., McBride, D., van Asperen, C., (2014) 'Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study', Eur Urol.

Killick, E., Tymrakiewicz, M., Cieza-Borrella, C., Smith, P., Thompson, D.J., Pooley, K.A., Easton, D.F., Bancroft, E., Page, E., Leongamornlert, D., IMPACT Collaborators., Kote-Jarai, Z., Eeles R.A., (2014) 'Telomere Length Shows no Association with BRCA1 and BRCA2 Mutation Status', PLoS One., 9(1). 

Killick, E., Morgan, R., Launchbury, F., Bancroft, E., Page, E., Castro, E., Kote-Jarai, Z., Aprikian, A., Blanco, I., Clowes, V., Domchek, S., Douglas, F., Eccles, D., Evans, D.G., Harris, M., Kirk, J., Lam, J., Lindeman, G., Mitchell, G., Pachter, N., Selkirt, C., Tucker, K., Zgajnar, J., Eeles, R., Pandha, H., (2013) 'Role of Engrailed-2 (EN2) as a Prostate Cancer Detection Biomarker in Genetically High Risk Men', Sci Rep.

Mitra, A.V., Bancroft, E.K., Barbachano, Y., Page, E.C., Foster, C.S., Jameson, C., Mitchell, G., Lindeman, G.J., Stapleton, A., Suthers, G., Evans, D.G., Cruger, D., Blanco, I., Mercer, C., Kirk, J., Maehle, L., Hodgson, S., Walker, L., Izatt, L., Douglas, F., Tucker, K., Dorkins, H., Clowes, V., Male, A., Donaldson, A., Brewer, C., Doherty, R., Bulman, B., Osther, P.J., Salinas, M., Eccles, D., Axcrona, K., Jobson, I., Newcombe, B., Cybulski, C., Rubinstein, W.S., Buys, S., Townshend, S., Friedman, E., Domchek, S., Ramon y Cajal, T., Spigelman, A., Teo, S.H., Nicolai, N., Aaronson, N., Ardern-Jones, A., Bangma, C., Dearnaley, D., Eyfjord, J., Falconer, A., Gronberg, H., Hamdy, F., Johannsson, O., Khoo, V., Kote-Jarai, Z., Lija, H., Lubinski, J., Melia, J., Moynihan, C., Peock, S., Rennert, G., Schroder, F., Sibley, P., Suri, M., Wilson, P., Bignon, Y.J., Strom, S., Tischkowitz, M., Liljegren, A., Ilenckiova, D., Abele, A., Kyriacou, K., van Asperen, C., Kiemeney, L., (2010) 'Targeted Prostate Cancer Screening in Men with Mutations in BRCA1 and BRCA2 Detects Aggressive Prostate Cancer: Preliminary Analysis of the Results of the IMPACT Study', BJUI.

Mitra, A.V., Jameson, C., Barbachano, Y., Sodha, N., Kote-Jarai, Z., Javed, A., Bancroft, E., Fletcher, A., Cooper, C., Peock, S., Easton, D., Eeles, R., Foster, C.S., (2010) 'Elevated Expression of Ki-67 identifies aggressive prostate cancer but does not distinguish BRCA1 and BRCA2 mutation carriers', Oncol Rep., 23(2), pp. 299-305.

Whitaker, H., Kote-Jarai, Z., Ross-Adams, H., Warren, A., Burge, A., George, A., Bancroft, E., Jhavar, S., Leongamornlert, D., Tymrakiewicz, M., Saunders, E., Page, E., Mitra, A., Mitchell, G., Lindeman, G., Evans, D.G., Blanco, I., Mercer, S., Rubinstein, W.S., Clowes, V., Douglas, F., Hodgson, S., Walker, L., Donaldson, A., Izatt, L., Dorkins, H., Male, A., Tucker, K., Stapleton, A., Lam, J., Lilja, H., Easton, D., The IMPACT Study Steering Committee., The IMPACT Study Collaborators., Cooper, C., Eeles, R., Neal, D., (2010) 'The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine', PLoS ONE., 5(10).

Mitra, A., Jameson, C., Barbachano, Y., Sodha, N., Kote-Jarai, Z., Javed, A., Bancroft, E., Fletcher, A., Foster, C.C., Cooper, C., Peock, S., Easton, D., Eeles, R., (2009) 'Overexpression of TP53 is Associated with Aggressive Prostate Cancer but does not Distinguish Disease in BRCA1 or BRCA2 Mutation Carriers from a Control Group', The Open Prostate Cancer Journal., 22, p.p. 38-45.

Mitra, A., Fisher, C., Foster, C.S., Jameson, C., Barbachano, Y., Bartlett, J., Bancroft, E., Doherty, R., Kote-Jarai, Z., Peock, S., Easton, D., Eeles, R., (2008)  'Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype', British J Cancer., 98, p.p. 502-7.

Mercer, C., Eccles, D., Mitra, A., Bancroft, E., Eeles, R., (2007) 'The Genetics of Prostate Cancer and the Potential for Targeted Screening: the IMPACT study', Oncology News., 2(2).

Mitra, A.V., Bancroft, E.K., Eeles, R.A., IMPACT Steering Committee and Collaborators., (2007)  'A Review of Targeted Screening For Prostate Cancer: Introducing the IMPACT Study',  BJU Int., 99(6), p.p. 1350-5.

Morgan, S., Doherty, R., Lubinski, J., Manguoglu, E., Luleci, G., Christie, M., Craven, P., Bancroft, E., Mitra, A., Morgan, S., Eeles, R., (2006) 'AIDIT and IMPACT: Strengthening Research Ties Across Eastern Europe', HCCP., 4(2), p.p. 111-112.

Doherty, R., Lubinsi, J., Manguoglu, E., Luleci, G., Christie, M., Craven, P., Bancroft, E., Mitra, A., Morgan, S., Eeles, R., (2006) 'AIDIT and IMPACT: Building Research Collaborations in Targeted Prostate Cancer Screening', J BUON., 11(4), p.p. 415-8.

 Abstracts

Mitra A, Bancroft E, Eeles R et al Targeted Screening in Men with a Genetic Predisposition to Prostate Cancer. The IMPACT Study. Clin Oncol (R Coll Radiol). (2007) Apr;19(3 Suppl):Abstract S39-40

Mitra AV, Bancroft EK, Eeles RA Identification of men with a genetic predisposition to prostate cancer: Targeted screening in BRCA1/2 mutation carriers and controls. The IMPACT study (2007). American Society Clinical Oncology (ASCO) Prostate Cancer Symposium Feb Abstract No.42

Mitra A, Bancroft E, Eeles R et al. Targeted Screening in Men with a Genetic Predisposition to Prostate Cancer The IMPACT Study (2006). British Prostate Group, Autumn meeting

Mitra A, Bancroft E, Eeles R. Identification of Men with a Genetic Predisposition to Prostate Cancer – Targeted Screening in BRCA1/2 Mutation Carriers and Controls: the IMPACT Study. (2006) 11th International Congress of Human Genetics, Brisbane Australia.